According to the new market research report "Genotyping Assay Market by Technology (PCR, Sequencing, Microarray, Electrophoresis, MALDI-TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), and Product - Global Forecast to 2023", published by MarketsandMarkets™, the Genotyping Assay Market is expected to reach USD 31.9 billion by 2023 from an estimated USD 11.8 billion in 2018, at a CAGR of 22.0%. The major factors driving the growth of this market include technological advancements, the decreasing prices of DNA sequencing, and the increasing incidence of genetic diseases.
Click the link to get a Sample Copy of the Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=249958595
Browse in-depth TOC on "Genotyping Assay Market"
219 - Tables
53 - Figures
280 - Pages
This market study covers and analyzes the potential of the global Genotyping Assay Market industry, providing geometric information about market dynamics, growth factors, major challenges, PEST analysis and market entry strategy analysis, opportunities and forecasts. One of the major highpoints of the report is to provide companies in the industry with a strategic analysis of the impact of COVID-19 on Genotyping Assay Market.
Genotyping Assay Market: Competition Landscape
The Genotyping Assay Market report includes information on the product presentations, sustainability and prospects of leading player including: Thermo Fisher Scientific (US), Illumina (US), QIAGEN (Netherlands), Agilent Technologies (US), Danaher Corporation (US), Roche Diagnostics (Switzerland), GE Healthcare (US), Fluidigm Corporation (US), PerkinElmer (US), Eurofins Scientific (Luxembourg), Bio-Rad Laboratories (US), Pacific Biosciences of California (US), GENEWIZ (US), and Integrated DNA Technologies (US)
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249958595
Genotyping Assay Market: Segmentation
Genotyping Market, By Product & Service
- Reagents & Kits
- Genotyping Services
- Instruments
- Sequencers & Amplifiers
- Analyzers
- Bioinformatics
- Software
- Services
Genotyping Market, By Technology
- PCR
- Real-time PCR
- Digital PCR
- Microarrays
- Sequencing
- NGS
- Pyrosequencing
- Sanger Sequencing
- Capillary Electrophoresis
- Amplified Fragment Length Polymorphism
- Restricted Fragment Length Polymorphism
- Single-stranded Conformation Polymorphism
- MALDI-TOF
- Other Technologies (Allele-specific Oligonucleotide (ASO) Probes and Fluorescence In Situ Hybridization (FISH))
Genotyping Market, By Application
- Pharmacogenomics
- Diagnostic & Personalized Medicine
- Agricultural Biotechnology
- Animal Genetics
- Other Applications (Prenatal Testing, Human Forensics, Microbial Genomic Studies, and Aquaculture Breeding Studies)
Genotyping Market, By End User
- Pharmaceutical and Biopharmaceutical Companies
- Diagnostic and Research Laboratories
- Academic Institutes
- Other End Users (Animal and Aqua Genetics Companies, Greenhouses, and Farms)
Genotyping Assay Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Genotyping Assay Market report are North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and Latin America.
Key Benefits of the report:
- This study presents the analytical description of the global Genotyping Assay Market industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Genotyping Assay Market share.
- The current market is quantitatively analyzed from 2022 to 2026 to highlight the global Genotyping Assay Market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & sellers in the market.
- The report provides a detailed global Genotyping Assay Market analysis based on competitive intensity and how the competition will take shape in the coming years.
Make an Enquire to Buy This Report @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=249958595
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/genotyping-market.asp
Visit Our Website: https://www.marketsandmarkets.com